Melatonin (1,9mg) Melotime™ – High potency and sequential release
Sequential release melatonin (Melotime™) (1,9mg Melatonin) from EssentialSeries is a dietary supplement in tablet form, designed to provide advanced and prolonged support for rest.
Formulated with patented Melotime™ technology, this melatonin works in two distinct phases: one fraction is released immediately to help you fall asleep, and the rest is gradually released throughout the night. Each tablet contains 4,2mg of Melotime™, equivalent to 1,9mg of pure melatonin.
A formula for those who need more than traditional melatonin: higher potency, optimal duration, and comprehensive night support.
Melotime™ dual release technology
Initial phase: fast action before bedtime
The immediate release fraction kicks in minutes after taking it, making sure melatonin is available right when your body starts the transition to sleep.
This first phase helps the natural start of rest, especially for people who have trouble “switching off” at the end of the day.
Prolonged phase: sustained release throughout the night
The second phase, thanks to Melotime™'s sequential granulation system, guarantees a prolonged release of the compound during sleep hours, providing a stable and sustained release throughout the entire night.
This feature makes it an optimal option for those who prefer melatonin that mimics the natural pattern of endogenous nocturnal secretion, Melotime™ respects physiological circadian rhythms.
The most studied compound for sleep and jet lag
Reduces the time needed to fall asleep
- Melatonin helps reduce the time needed to fall asleep1.
Thanks to its biphasic release profile, this formula acts exactly when the body needs it, delivering results from the very first use.
Relieves jet lag on trips with time zone changes
- Melatonin helps relieve the subjective feeling of jet lag2.
Especially useful for frequent travelers and professionals on the move, this formulation helps restore the circadian rhythm disrupted by time zone changes.
True clean label: only what’s necessary
At HSN we’re committed to transparency, safety, and functionality. This high-potency melatonin formula includes only:
- Melotime™ sequential release melatonin: functional nutrient.
- Microcrystalline cellulose: natural compression agent, needed to make the tablet.
- Vegetable coating (HPMC + glycerin): stabilizes the tablet shape without artificial additives, and prevents loose “dust” in the bottle.
No allergens, no GMOs, no colorants or sweeteners. Suitable for vegans.
Who is this melatonin for?
It’s especially designed for:
- Users who have already tried low-dose melatonin (1mg or less), and are looking for a more potent version.
- People who occasionally or persistently have trouble falling asleep.
- International travelers and professionals on rotating shifts.
Thanks to its excellent tolerance, it can be used daily, long-term, without breaks, without causing tolerance or dependence.
Frequently asked questions (FAQ)
What’s the difference between this melatonin and the 1mg one?
This version offers almost double the pure melatonin, designed for those who need a stronger effect. Its sequential release remains, but with a higher concentration per tablet.
If you prefer the option of Sequential release melatonin (Melotime™) (1mg Melatonin), you can find it here.
Is it suitable for daily use?
Continuous daily use causes no issues; studies have evaluated its effects and any possible adverse effects from daily use of different melatonin doses over years, and results are positive: it keeps working and causes no problems.
Can I combine it with other dietary supplements?
Yes. It’s compatible with other compounds like magnesium, glycine, GABA, L-theanine, among others, since melatonin has no known contraindications for combined use.
Does it cause drowsiness the next day?
The controlled release of Melotime™ doesn’t cause “hangover” effects upon waking the next day.
Can an elderly person take it?
Yes. In fact, endogenous melatonin secretion decreases with age, so this formula can offer especially useful physiological support.
References
- Zwart, T. C., Smits, M. G., Egberts, T. C. G., Rademaker, C. M. A., & van Geijlswijk, I. M. (2018). Long-term melatonin therapy for adolescents and young adults with chronic sleep onset insomnia and late melatonin onset: Evaluation of sleep quality, chronotype, and lifestyle factors compared to age-related randomly selected population cohorts. Healthcare, 6(1), 23.
- Ferracioli-Oda, E., Qawasmi, A., & Bloch, M. H. (2013). Meta-analysis: Melatonin for the treatment of primary sleep disorders. PLoS ONE, 8(5), e63773.
- Li, T., Jiang, S., Han, M., Yang, Z., Lv, J., Deng, C., Zhang, Y., Su, H., Li, C., & Yang, Y. (2019). Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis. Frontiers in Neuroendocrinology, 52, 22–28.
- Peuhkuri, K., Sihvola, N., & Korpela, R. (2012). Dietary factors and fluctuating levels of melatonin. Food & Nutrition Research, 56, 17252.
1 The beneficial effect is obtained with an intake of 1mg of melatonin shortly before going to sleep.
2 The beneficial effect is obtained with a minimum intake of 0,5mg, shortly before bedtime on the first day of travel and the days following arrival at the destination.
Delivery in 3-5 working days
Before
After
During
Morning
Afternoon
Night
